A phase I dose-escalation study of selumetinib in combination with docetaxel or dacarbazine in patients with advanced solid tumors. - LoRusso, Patricia M.; Infante, Jeffrey R.; Kim, Kevin B.; Burris, Howard A.; Curt, Gregory; Ugochi Emeribe; Clemett, Delyth; Tomkinson, Helen K.; Cohen, Roger B.; Burris, Howard A 3rd; Emeribe, Ugochi (BMC Cancer, 2017)